查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390743

2023-2028 年智慧藥丸市場報告（按目標領域、疾病適應症、應用、最終用戶和地區）

Smart Pills Market Report by Target Area, Disease Indication, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球智慧藥丸市場規模達到43億美元。展望未來， IMARC Group預計到2028年市場規模將達到67億美元，2022-2028年複合年成長率（CAGR）為7.67%。老年族群對慢性病管理的需求增加、技術的快速進步、微創手術（MIS）的新興趨勢、製藥業對個人化醫療和藥物輸送的日益關注是推動市場的一些主要因素。

智慧藥丸，也稱為數位藥丸或可攝入感測器，是一種創新藥物，配備微型電子元件，可實現遠端監控和資料收集。這些藥丸通常包含感測器、微晶片和發射器，供患者服用。一旦進入體內，它們就會與體液相互作用，將有關患者健康指標、藥物依從性和生理反應的即時資料發送到外部設備。醫療保健提供者和研究人員利用這些資料來加強患者護理、最佳化治療計劃並改善藥物開發。智慧藥丸透過增強監測和資料收集能力，為個人化醫療、慢性病管理和臨床試驗提供潛在好處。

在全球人口老化的推動下，全球智慧藥丸市場正在經歷大幅成長，導致慢性病盛行率增加，需要對患者的健康狀況進行持續監測和管理。智慧藥丸提供了一種非侵入性且有效的方式來收集即時健康資料，使其成為遠端患者監測和疾病管理的寶貴工具。此外，微型電子和無線通訊技術的進步使得開發和生產智慧藥丸更具成本效益，增加了醫療保健提供者和患者的可及性，這為市場擴張創造了積極的前景。除此之外，對個人化醫療的需求不斷成長以及對精確藥物輸送系統的需求促使製藥公司和研究人員投資智慧藥丸技術，也促進了市場的成長。此外，COVID-19 大流行推動了遠距醫療和遠端監控解決方案的採用，進一步推動了智慧藥丸市場的發展。

智慧藥丸市場趨勢/促進因素：

人口老化與慢性病管理

一個重要的促進因素是全球老年人口的增加。隨著人口平均年齡的增加，糖尿病、高血壓、心血管疾病等慢性疾病的盛行率也增加。管理這些病症通常需要持續監測和堅持用藥。智慧藥丸透過提供有關患者健康指標的非侵入性即時資料收集來提供創新的解決方案。這種遠端監測功能對於難以採用傳統監測方法的老年患者尤其有價值。醫療保健提供者可以利用智慧藥丸的資料及時進行干預，調整治療計劃，並確保更好的疾病管理，從而提高老齡化人口的護理品質。

持續的技術進步

微型電子、感測器和無線通訊技術的進步極大地促進了智慧藥丸市場的成長。這些技術進步促進了更小、更容易服用的智慧藥丸的開發，提高了患者的舒適度和依從性，同時減少了服用過程中出現不適或阻力的可能性。此外，組件的小型化不僅降低了製造成本，還提高了智慧藥丸的整體效率和壽命。因此，醫療保健提供者和患者受益於更容易獲得和更具成本效益的解決方案，而智慧藥丸收集的資料的準確性和可靠性得到了提高，在醫學界得到了越來越多的認可，有助於市場擴張。

對個人化醫療和新型藥物輸送的需求不斷成長

製藥業對個人化醫療和精確藥物輸送系統日益成長的興趣是另一個促進因素。智慧藥丸提供了一種將藥物直接給藥到體內目標部位的獨特方法。這種標靶藥物傳遞可以增強治療效果，同時最大限度地減少副作用。製藥公司擴大投資智慧藥丸技術，作為改善藥物開發的手段，確保藥物適合個別患者的需求。除此之外，智慧藥丸還可用於臨床試驗，收集藥物效果的即時資料，簡化研究過程，並有可能加快新療法推向市場的速度。

智慧藥丸產業細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據目標區域、疾病適應症、應用和最終用戶對市場進行了分類。

按目標區域分類：

食道

小腸

大腸

胃

小腸佔據市場主導地位

該報告根據目標區域提供了詳細的市場區隔和分析。這包括食道、小腸、大腸和胃。根據報告，小腸是最大的部分。

針對小腸的智慧藥丸的需求源自於其獨特的進入和監測消化道特定區域的能力。小腸在營養吸收中起著至關重要的作用，使其成為各種胃腸道疾病和藥物傳輸挑戰的焦點。設計用於該區域的智慧藥丸可以精確了解營養吸收效率，從而可以針對吸收不良症候群等病症提供量身定做的飲食建議和治療方法。此外，它們的應用也擴展到藥物傳輸最佳化，確保藥物到達預期的作用部位，這對於需要在小腸吸收的治療尤其相關。因此，由於其滿足特定醫療保健需求和增強治療效果的潛力，對小腸量身定做的智慧藥丸的需求持續上升。

按疾病指示細分：

食道疾病

小腸疾病

結腸疾病

其他

報告還根據疾病跡象提供了詳細的市場細分和分析。這包括食道疾病、小腸疾病、結腸疾病等。

由於智慧藥丸能夠在胃腸道的這些特定區域提供精確、即時的資料，因此對治療食道、小腸和結腸疾病的智慧藥丸的需求激增，這正在加強市場的成長。此外，胃食道逆流症 (GERD) 等食道疾病的盛行率不斷上升，其中智慧藥丸有助於監測 pH 值並追蹤胃酸逆流模式，從而有助於診斷和管理這些疾病。除此之外，在克隆氏症或乳糜瀉等小腸疾病中，這些藥丸可以幫助追蹤通過和運輸時間，使臨床醫生能夠評估腸道蠕動和炎症，而在結腸疾病，特別是結直腸癌篩查中，配備成像功能的智慧藥丸可以捕捉詳細的影像，增強早期檢測並減少侵入性手術的需要。這種有針對性的監測和診斷潛力正在推動食道、小腸和結腸疾病領域對智慧藥丸的需求，從而改善患者護理和治療結果。

按應用分類：

膠囊內視鏡

藥物輸送

病人監護

膠囊內視鏡主導市場

該報告根據應用程式提供了詳細的市場細分和分析。這包括膠囊內視鏡檢查、藥物傳輸和患者監測。根據該報告，膠囊內視鏡佔最大部分。

與傳統內視鏡檢查不同，配備成像技術的智慧藥丸為胃腸道可視化提供了一種無痛且患者友好的替代方案。這導致了接受度和患者依從性的提高，特別是在傳統內視鏡檢查可能不舒服或具有挑戰性的情況下。此外，使用智慧藥丸進行膠囊內視鏡檢查對於診斷和監測不明原因胃腸道出血、克隆氏症和小腸腫瘤等疾病特別有價值。這些智慧藥丸捕獲的高品質影像和即時資料可以實現早期檢測和精確定位異常，從而促進及時干預並改善患者治療結果。因此，膠囊內視鏡對智慧藥丸的需求持續成長，從而提高了醫療保健專業人員的診斷能力和患者體驗。

按最終用戶分類：

醫院

診斷中心

研究機構

診斷中心佔市場最大佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、診斷中心和研究機構。報告稱，診斷中心佔據最大的市場佔有率。

診斷中心對智慧藥丸的需求不斷成長，透過提供一種對患者友好、非侵入性的方法來增強診斷程序，從而促進了市場的擴張。這些設備提供即時胃腸道資料，有助於精確診斷，特別是對於胃腸道出血、蠕動障礙和小腸疾病等疾病。智慧藥丸的成像功能、pH 評估和傳輸監測為臨床醫生提供了胃腸道健康的全面視圖，減少了對不舒服的侵入性手術的需求。這提高了患者的舒適度、依從性和診斷準確性，使患者和醫療保健提供者受益，並有助於診斷中心擴大採用智慧藥丸。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的智慧藥丸市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

北美強大的醫療基礎設施，包括先進的診斷中心和研究機構，正在促進智慧藥丸用於創新診斷和研究目的的採用。同時，發炎性腸道疾病和大腸直腸癌等胃腸道疾病的盛行率不斷上升，對智慧藥丸等非侵入性診斷工具產生了很高的需求，這些工具可以提高患者的舒適度和依從性。此外，該地區的人口老化以及對慢性病管理的需求不斷成長，將智慧藥丸視為遠端患者監測的寶貴解決方案。除此之外，北美有利的報銷政策和監管框架正在鼓勵醫療保健提供者和製藥公司投資智慧藥丸技術。除此之外，該地區的技術創新和領先公司的早期市場進入為北美智慧藥丸市場的成長奠定了堅實的基礎。

競爭格局：

全球智慧藥丸市場呈現出一個競爭格局，既有老牌企業，也有新興企業，他們都在努力利用對遠距病患監測和創新醫療解決方案不斷成長的需求。領先企業憑藉較早的市場進入、強大的研發能力和廣泛的分銷網路佔據了巨大的市場佔有率。他們提供各種智慧藥丸產品，融合了先進的感測器技術和資料分析平台。此外，與醫療保健提供者和製藥公司的夥伴關係和合作進一步鞏固了他們的市場地位。同時，許多新創公司和小型公司正在透過顛覆性技術和智慧藥丸的新穎應用積極為市場成長做出貢獻，加劇競爭並推動產業創新。

市場研究報告對競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

凱普索視覺公司

檢查帽有限公司

通用電氣公司

英卓醫療股份有限公司

金山科技（集團）有限公司

皇家飛利浦公司

美敦力公司

奧林巴斯公司

賓得醫療（豪雅公司）。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

最近的發展：

2020 年，CapsoVision Inc.（美國）的總部和 CapsoCloud 軟體都獲得了 ISO 27001 安全認證，並重申了對保護客戶資料的堅定不移的承諾。

本報告回答的關鍵問題：

  • 迄今為止，全球智慧藥丸市場表現如何，未來幾年將如何表現？
  • 全球智慧藥丸市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球智慧藥丸市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的智慧藥丸市場？
  • 基於目標區域的市場區隔是什麼？
  • 智慧藥丸市場最有吸引力的目標領域是哪個？
  • 根據疾病跡象，市場的細分是什麼？
  • 智慧藥丸市場上最具吸引力的疾病適應症是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 智慧藥丸市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 智慧藥丸市場中哪一個對最終用戶最具吸引力？
  • 全球智慧藥丸市場競爭格局如何？
  • 誰是全球智慧藥丸市場的主要參與者/公司？

本報告回答的關鍵問題：

  • 迄今為止，全球智慧藥丸市場表現如何，未來幾年將如何表現？
  • 全球智慧藥丸市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球智慧藥丸市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的智慧藥丸市場？
  • 基於目標區域的市場區隔是什麼？
  • 智慧藥丸市場最有吸引力的目標領域是哪個？
  • 根據疾病跡象，市場的細分是什麼？
  • 智慧藥丸市場上最具吸引力的疾病適應症是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 智慧藥丸市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 智慧藥丸市場中哪一個對最終用戶最具吸引力？
  • 全球智慧藥丸市場競爭格局如何？
  • 誰是全球智慧藥丸市場的主要參與者/公司？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球智慧藥丸市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按目標區域分類的市場區隔

  • 食道
    • 市場走向
    • 市場預測
  • 小腸
    • 市場走向
    • 市場預測
  • 大腸
    • 市場走向
    • 市場預測
  • 胃
    • 市場走向
    • 市場預測

第 7 章：依疾病適應症分類的市場

  • 食道疾病
    • 市場走向
    • 市場預測
  • 小腸疾病
    • 市場走向
    • 市場預測
  • 結腸疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場區隔

  • 膠囊內視鏡
    • 市場走向
    • 市場預測
  • 藥物輸送
    • 市場走向
    • 市場預測
  • 病人監護
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 研究機構
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • CapsoVision Inc.
    • Check-Cap Ltd.
    • General Electric Company
    • IntroMedic Co. Ltd.
    • Jinshan Science & Technology (Group) Co. Ltd.
    • Koninklijke Philips NV
    • Medtronic plc
    • Olympus Corporation
    • PENTAX Medical (Hoya Corporation)
Product Code: SR112023A4568

Abstract

The global smart pills market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.67% during 2022-2028. The increased demand for chronic disease management among the geriatric population, rapid technological advancements, emerging trend of minimally invasive surgeries (MIS), the increasing focus of pharmaceutical industry on personalized medicine and drug delivery are some of the major factors propelling the market.

Smart pills, also known as digital pills or ingestible sensors, are innovative pharmaceuticals equipped with tiny electronic components that enable remote monitoring and data collection. These pills typically contain sensors, microchips, and transmitters, which are ingested by patients. Once inside the body, they interact with bodily fluids, sending real-time data about a patient's health metrics, medication adherence, and physiological responses to external devices. Healthcare providers and researchers use this data to enhance patient care, optimize treatment plans, and improve drug development. Smart pills offer potential benefits in personalized medicine, chronic disease management, and clinical trials by enhancing monitoring and data acquisition capabilities.

The global smart pills market is experiencing substantial growth driven by the aging population across the globe has resulted in an increased prevalence of chronic diseases, requiring continuous monitoring and management of patient's health. Smart pills offer a non-invasive and efficient way to collect real-time health data, making them a valuable tool for remote patient monitoring and disease management. Moreover, advancements in miniaturized electronics and wireless communication technologies have made it more cost-effective to develop and produce smart pills, increasing their accessibility to healthcare providers and patients, which is creating a positive outlook for market expansion. In addition to this, the rising demand for personalized medicine and the need for precise drug delivery systems prompting pharmaceutical companies and researchers to invest in smart pill technology, are contributing to the market growth. Furthermore, the COVID-19 pandemic has fueled the adoption of telehealth and remote monitoring solutions, further boosting the market for smart pills.

Smart Pills Market Trends/Drivers:

Aging population and chronic disease management

One significant driver is the increasing geriatric population across the globe. As the average age of the population rises, so does the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Managing these conditions often requires continuous monitoring and medication adherence. Smart pills provide an innovative solution by offering non-invasive, real-time data collection on a patient's health metrics. This remote monitoring capability is particularly valuable for elderly patients who may have difficulty with conventional monitoring methods. Healthcare providers can use the data from smart pills to make timely interventions, adjust treatment plans, and ensure better disease management, improving the quality of care for aging populations.

Ongoing technological advancements

Advancements in miniaturized electronics, sensors, and wireless communication technologies have significantly contributed to the growth of the smart pills market. These technological strides have led to the development of smaller, more easily ingestible smart pills, enhancing patient comfort and compliance while reducing the potential for discomfort or resistance during ingestion. Moreover, the miniaturization of components has not only reduced manufacturing costs but also improved the overall efficiency and longevity of smart pills. As a result, healthcare providers and patients benefit from more accessible and cost-effective solutions, while the enhanced accuracy and reliability of the data collected by smart pills have garnered increased acceptance within the medical community, aiding in market expansion.

Growing demand for personalized medicine and novel drug delivery

The pharmaceutical industry's growing interest in personalized medicine and precise drug delivery systems is another driving factor. Smart pills offer a unique way to administer medications directly to the target site in the body. This targeted drug delivery can enhance the efficacy of treatments while minimizing side effects. Pharmaceutical companies are increasingly investing in smart pill technology as a means to improve drug development, ensuring that medications are tailored to individual patient needs. Apart from this, smart pills can be used in clinical trials to gather real-time data on the drug's effects, streamlining the research process and potentially speeding up the introduction of new therapies to the market.

Smart Pills Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on target area, disease indication, application and end user.

Breakup by Target Area:

Esophagus

Small Intestine

Large Intestine

Stomach

Small intestine dominate the market

The report has provided a detailed breakup and analysis of the market based on the target area. This includes esophagus, small intestine, large intestine, and stomach. According to the report, small intestine represented the largest segment.

The demand for smart pills targeting the small intestine is propelled by their unique ability to access and monitor this specific area of the digestive tract. The small intestine plays a crucial role in nutrient absorption, making it a focal point for various gastrointestinal disorders and drug delivery challenges. Smart pills designed to operate in this region offer precise insights into nutrient absorption efficiency, allowing for tailored dietary recommendations and treatments for conditions, such as malabsorption syndromes. Furthermore, their application extends to drug delivery optimization, ensuring medications reach the intended site of action, which is especially relevant for treatments that require absorption in the small intestine. As a result, the demand for smart pills tailored to the small intestine continues to rise, driven by their potential to address specific healthcare needs and enhance therapeutic outcomes.

Breakup by Disease Indication:

Esophageal Diseases

Small Bowel Diseases

Colon Diseases

Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes esophageal diseases, small bowel diseases, colon diseases, and others.

The surging demand for smart pills in addressing esophageal, small bowel, and colon diseases owing to their capacity to provide precise, real-time data in these specific areas of the gastrointestinal tract is strengthening the market growth. Moreover, the growing prevalence of esophageal diseases such as gastroesophageal reflux disease (GERD), wherein smart pills help monitor pH levels and track acid reflux patterns, aiding in the diagnosis and management of these conditions. Apart from this, in small bowel diseases like Crohn's disease or celiac disease, these pills can help track the passage and transit time, enabling clinicians to assess motility and inflammation, while in colon diseases, particularly colorectal cancer screening, smart pills equipped with imaging capabilities can capture detailed images, enhancing early detection and reducing the need for invasive procedures. This targeted monitoring and diagnostic potential are propelling the demand for smart pills in the context of esophageal, small bowel, and colon diseases, improving patient care and outcomes.

Breakup by Application:

Capsule Endoscopy

Drug Delivery

Patient Monitoring

Capsule endoscopy dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes capsule endoscopy, drug delivery, and patient monitoring. According to the report, capsule endoscopy represented the largest segment.

Unlike traditional endoscopy, smart pills equipped with imaging technology provide a painless and patient-friendly alternative for visualizing the gastrointestinal tract. This has led to increased acceptance and patient compliance, especially in cases where traditional endoscopy may be uncomfortable or challenging. Additionally, capsule endoscopy using smart pills is particularly valuable for diagnosing and monitoring conditions such as obscure gastrointestinal bleeding, Crohn's disease, and small bowel tumors. The high-quality images and real-time data captured by these smart pills allow for early detection and precise localization of abnormalities, thereby facilitating timely interventions and improving patient outcomes. Consequently, the demand for smart pills in capsule endoscopy continues to grow, enhancing the diagnostic capabilities of healthcare professionals and patient experiences.

Breakup by End User:

Hospitals

Diagnostic Centers

Research Institutes

Diagnostic centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, diagnostic centers, and research institutes. According to the report, diagnostic centers accounted for the largest market share.

The rising demand for smart pills in diagnostic centers is bolstering market expansion by offering a patient-friendly, non-invasive approach to enhance diagnostic procedures. These devices provide real-time gastrointestinal data, aiding precise diagnoses, especially for conditions like gastrointestinal bleeding, motility disorders, and small bowel diseases. Smart pills' imaging capabilities, pH assessment, and transit monitoring provide clinicians with a comprehensive view of GI health, reducing the need for uncomfortable invasive procedures. This improves patient comfort, compliance, and diagnostic accuracy, benefiting both patients and healthcare providers, and contributing to the growing adoption of smart pills in diagnostic centers.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart pills market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, including advanced diagnostic centers and research institutions, is facilitating the adoption of smart pills for innovative diagnostic and research purposes. Concurrently, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer, has created a high demand for non-invasive diagnostic tools like smart pills, which offer improved patient comfort and compliance. Moreover, the region's aging population, with a growing need for chronic disease management, sees smart pills as an invaluable solution for remote patient monitoring. Besides this, favorable reimbursement policies and regulatory frameworks in North America are encouraging healthcare providers and pharmaceutical companies to invest in smart pill technology. Apart from this, the region's technological innovation and early market entry by leading companies have established a strong foundation for the growth of the North America smart pills market.

Competitive Landscape:

The global smart pills market presents a competitive landscape characterized by a mix of established players and emerging entrants striving to capitalize on the growing demand for remote patient monitoring and innovative healthcare solutions. Leading companies hold substantial market shares, primarily due to their early market entry, robust R&D capabilities, and extensive distribution networks. They offer a diverse range of smart pill products, incorporating advanced sensor technologies and data analytics platforms. Moreover, partnerships and collaborations with healthcare providers and pharmaceutical companies have further solidified their market position. At the same time, numerous startups and smaller companies, are actively contributing to market growth with disruptive technologies and novel applications of smart pills, intensifying competition and driving innovation in the industry.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

CapsoVision Inc

Check-Cap Ltd.

General Electric Company

IntroMedic Co. Ltd.

Jinshan Science & Technology (Group) Co. Ltd.

Koninklijke Philips N.V.

Medtronic plc

Olympus Corporation

PENTAX Medical (Hoya Corporation).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In 2020, CapsoVision Inc. (US) attained ISO 27001 security certification for both its headquarters and CapsoCloud software, reaffirming its unwavering dedication to safeguarding customer data.

Key Questions Answered in This Report:

  • How has the global smart pills market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global smart pills market?
  • What is the impact of each driver, restraint, and opportunity on the global smart pills market?
  • What are the key regional markets?
  • Which countries represent the most attractive smart pills market?
  • What is the breakup of the market based on the target area?
  • Which is the most attractive target area in the smart pills market?
  • What is the breakup of the market based on the disease indication?
  • Which is the most attractive disease indication in the smart pills market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the smart pills market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the smart pills market?
  • What is the competitive structure of the global smart pills market?
  • Who are the key players/companies in the global smart pills market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Pills Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Target Area

  • 6.1 Esophagus
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Intestine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Large Intestine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Stomach
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Disease Indication

  • 7.1 Esophageal Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Small Bowel Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colon Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Capsule Endoscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Patient Monitoring
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CapsoVision Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Check-Cap Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 General Electric Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 IntroMedic Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Jinshan Science & Technology (Group) Co. Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Koninklijke Philips N.V.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Olympus Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PENTAX Medical (Hoya Corporation)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Smart Pills Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Pills Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Smart Pills Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Smart Pills Market: Breakup by Target Area (in %), 2022
  • Figure 5: Global: Smart Pills Market: Breakup by Disease Indication (in %), 2022
  • Figure 6: Global: Smart Pills Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Smart Pills Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Smart Pills Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Smart Pills (Esophagus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Smart Pills (Esophagus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Smart Pills (Small Intestine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Smart Pills (Small Intestine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Smart Pills (Large Intestine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Smart Pills (Large Intestine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Smart Pills (Stomach) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Smart Pills (Stomach) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Smart Pills (Esophageal Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Smart Pills (Esophageal Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Smart Pills (Small Bowel Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Smart Pills (Small Bowel Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Smart Pills (Colon Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Smart Pills (Colon Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Smart Pills (Other Disease Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Smart Pills (Other Disease Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Smart Pills (Capsule Endoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Smart Pills (Capsule Endoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Smart Pills (Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Smart Pills (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Smart Pills (Patient Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Smart Pills (Patient Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Smart Pills (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Smart Pills (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Smart Pills (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Smart Pills (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Smart Pills (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Smart Pills (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Smart Pills Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Smart Pills Industry: SWOT Analysis
  • Figure 87: Global: Smart Pills Industry: Value Chain Analysis
  • Figure 88: Global: Smart Pills Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Pills Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Smart Pills Market Forecast: Breakup by Target Area (in Million US$), 2023-2028
  • Table 3: Global: Smart Pills Market Forecast: Breakup by Disease Indication (in Million US$), 2023-2028
  • Table 4: Global: Smart Pills Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Smart Pills Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Smart Pills Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Smart Pills Market: Competitive Structure
  • Table 8: Global: Smart Pills Market: Key Players